700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02214

Synthetic patientMETA-24 · Day 131 · 75+ · F · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Improving
Nutritional resilience
Declining
Discontinuation risk
26%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S08
  2. Day 24 Trajectory diverged from prediction — Observed response fell below the model's expected path.
  3. Day 71 SC-12 recommended — Supportive Compound SC-12
  4. Day 72 Patient accepted — Started SC-12 in the companion
  5. Day 78 No meaningful change — Supportive Compound SC-12

What changed?

Trajectory began diverging from predicted response on Day 24.

Primary contributors, last 14 days
  • Toxicity-22
  • GI instability+10
  • Inflammatory activity-7
  • Treatment adherence-5
  • Nutritional resilience-4

What helped?

  • Supportive Compound SC-12Day 71
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
38 min
stable · 0.0 vs previous 14 d
Sleep duration
Wearable
7 h
stable · +0.2 vs previous 14 d
Energy level
Daily log
6.3/10
stable · +0.0 vs previous 14 d
Steps
Wearable
3,946
stable · +145 vs previous 14 d
GI burden
Companion
21.3/100
improving · -2.1 vs previous 14 d
Adherence
Companion
90.7 %
worsening · -5.2 vs previous 14 d
Sleep quality
Wearable
46.2/100
stable · +1.8 vs previous 14 d
Glucose, CGM daily mean
CGM
123 mg/dL
stable · -1.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 81 from the failing basin, 10 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -3.4 next day on high-intake days · n 24
  • More caffeine
    GI -2.1 next day on high-intake days · n 13
Would not help
  • SC-12 Supportive Compound
    already tried, no meaningful change
  • Keep ultra-processed low
    GI +2.2 next day on high-intake days · n 21
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -3.4supporter · 95%
  • Ultra-processed food
    +2.2detractor · 77%
  • Caffeine
    -2.1supporter · 72%
  • Insoluble fibre
    -1.6no signal · 49%
  • Alcohol
    -1.2no signal · 22%
  • Dietary fat load
    +0.7no signal · 19%
  • Histamine load
    -0.7no signal · 19%
  • Simple carbohydrates
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity ↓30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Inflammatory signalling ↓25
    • DNAIL6 -174 variant raises baseline inflammatory tone
  • Butyrate / short-chain fatty acid production ↓25
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery ↓20
    • Wearable3,946 steps/day
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 4 · butyrate capacity 75/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
50 ms
Sleep
7.0 h
Steps
5,131
Resting HR
58 bpm
Daily log: GI score 21, nutritional resilience 66, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0262048%S01HY-01improved64
P-0246246%S12DT-01improved65
P-0269846%S06ME-01improved71
P-0251845%S17DT-01improved68
P-0253842%S02GI-04improved59
P-0206441%S04SC-12improved57
P-0235441%S01CR-01improved78
P-0208240%S12NP-02improved53
P-0212640%S16DT-01improved59
P-0214740%S13GI-04improved58
P-0264540%S02HY-01improved56
P-0221839%S01DT-01improved61